Impact of Ruxolitinib in Myelofibrosis Allogeneic Stem Cell Transplant Outcome---a Pilot Study

被引:0
|
作者
Poulose, Joyson
Malysz, Jozef
Claxton, David F.
Ehmann, W. Christopher
Mineishi, Shin
Rybka, Witold B.
Hohl, Raymond J.
Pu, Jeffrey J.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5543
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Outcome Predictors of Allogeneic Hematopoietic Stem Cell Transplant
    Yang, Wen-Chi
    Chen, Yih-Ting
    Chang, Wei-Wen
    Chang, Chih-Hsiang
    Fan, Pei-Chun
    Lee, Shen-Yang
    Kao, Kuo-Chin
    Tian, Ya-Chung
    Hung, Cheng-Chieh
    Fang, Ji-Tseng
    Yang, Chih-Wei
    Chen, Yung-Chang
    Wang, Po-Nan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (01): : 33 - 38
  • [42] IMPACT OF MOLECULAR REMISSION ON CLINICAL OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN 14 PATIENTS WITH MYELOFIBROSIS
    Casetti, I. C.
    Cavalloni, C.
    Rumi, E.
    Pietra, D.
    Sant'Antonio, E.
    Bellini, M.
    Milanesi, C.
    Ferretti, V.
    Boveri, E.
    Pascutto, C.
    Astori, C.
    Ripamonti, F.
    Della Porta, M.
    Caldera, D.
    Colombo, A. A.
    Bernasconi, P.
    Alessandrino, E. P.
    Cazzola, M.
    HAEMATOLOGICA, 2014, 99 : 667 - 667
  • [43] Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
    Gagelmann, N.
    Badbaran, A.
    Ditschkowski, M.
    Bogdanov, R.
    Panagiota, V
    Thol, F.
    Robin, M.
    Heuser, M.
    Beelen, D.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 58 - 59
  • [44] Myeloablative allogeneic stem cell transplant for AML and MDS: the impact of advanced age in the outcome
    Sanchez-Escamilla, M.
    Garcia-Avila, S.
    Yanez San Segundo, L.
    Bermudez Rodriguez, M. A.
    Colorado Araujo, M. M.
    Casado Diez, A.
    Celis Alvarez, M.
    Cabero Martinez, A.
    Fernandez Martinez, C.
    Insunza Garminde, A.
    Richard Espiga, C.
    Conde Garcia, E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S333 - S334
  • [45] Allogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis
    Tharakan, Serena
    Sastow, Dahniel
    van Hyfte, Grace
    Mascarenhas, John
    Keyzner, Alla
    Tremblay, Douglas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S433 - S433
  • [46] Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant
    Srour, Samer A.
    Desai, Parth
    Ciurea, Stefan O.
    Bashir, Qaiser
    Oran, Betul
    Olson, Amanda L.
    Ahmed, Sairah
    Bose, Prithviraj
    Mehta, Rohtesh S.
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Champlin, Richard E.
    Popat, Uday
    BLOOD, 2017, 130
  • [47] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [48] Ruxolitinib during Allogeneic Stem Cell Transplantation (allo-SCT) in Primary Myelofibrosis (PMF) Recommendation
    Tan, Yaxian
    Luo, Jie
    Zhou, Xuan
    Liu, Xiaoli
    Liu, Qifa
    Xu, Na
    BLOOD, 2020, 136
  • [49] Ruxolitinib-induced spleen size reduction predicts superior outcome after allogeneic stem cell transplantation in primary and post-PV/ET myelofibrosis - a study of the Cooperative German Transplant Study Group (KTS)
    Wolf, D. G. F.
    Jonas, J.
    Haifaa, A.
    Wulf, G.
    Wagner, E.
    Bornhaeuser, M.
    Schroeder, T.
    Crysant, M.
    Mayer, K.
    Brossart, P.
    Christopeit, M.
    Ayuk, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S73 - S74
  • [50] The Impact of Pre-Transplant Depression and Anxiety on the Outcome of Allogeneic Stem Cell Transplantation, a Study of the TCWP of the EBMT
    Peric, Zinaida
    Peczynski, Christophe
    Polge, Emmanuelle
    Kroger, Nicolaus
    Socie, Gerard
    Finke, Jurgen
    Holler, Ernst
    Blaise, Didier
    Helbig, Grzegorz
    Niittyvuopio, Riitta
    Potter, Victoria
    Bunjes, Donald
    Benedek, Istvan
    Penack, Olaf
    Schoemans, Helene
    Koenecke, Christian
    Basak, Grzegorz
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 758 - 758